Idxx Q4 2025 Earnings Idexx Laboratories Inc. Tops Analyst Eps Estimates 20260403 1 Jim Cramers Ongoing Investigation of Adobe Sparks Market Interest Tulsi Gabbard Resigns as Director of National Intelligence in Latest Cabinet Departure Plus500 Confirms FullYear Guidance After 11 Quarterly Revenue Increase Enhanced Games Donald Trump JrBacked Steroid Olympics to Debut in Las Vegas Tech Media Telecom Roundup Market Talks Highlight DeepSeek SoFi and Sector Trends Consumer Sentiment Falls to Record Low in May as Rising Gas Prices Amid Iran Conflict Weigh on Outlook High Templar Tech Limited HTT Q1 2023 Earnings Positive EPS Result Drives Sharp Stock Rally Jiayin Group Q4 2024 Earnings EPS Delivers Solid Profitability Stock Gains Over 6 MTH Q1 2026 Earnings EPS Misses Estimates as Homebuilder Navigates Housing Market Headwinds TC Q3 2021 Earnings Significant EPS Miss as Losses Widen SAMG Q1 2026 Earnings Earnings Miss as EPS Falls Short of Estimates OCS Q1 2026 Earnings WiderthanExpected Losses Amid Continued Pipeline Investment GrowGeneration Corp GRWG Gains 170 as Shares Test Key Resistance Levels Spire Global Surges Over 10 as Momentum Builds Toward Key Resistance Backblaze Inc BLZE Edges Higher in Quiet Trading Holding Above Key Support Levels TriMas Corporation TRS Holds Gains Near Resistance After 26 Rally Blackstone Secured Lending Fund BXSL Edges Lower as Support Levels Come Into Focus Barclays Raises Energy Transfer Price Target Signals Potential Upside Century Communities Q1 2026 Earnings Strong EPS Beat Amid Housing Market Headwinds ALX Oncology ALXO Edges Higher Amid Modest Buying Interest Resistance at 206 in Focus Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech HDSN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Reacts Negatively Primoris Services Corporation PRIM Q1 2026 Earnings EPS Misses Estimates but Stock Surges Over 10 QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies HBANL Q1 2026 Earnings Preferred Dividend Misses Estimates on Higher Provisioning MLYS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Ahead of Key Trial Data